RxDoctor Payments Data

Ziga Cizman, MD

Vascular & Interventional Radiology · Salt Lake City, UTNPI 1407176407

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (51.0%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 34.3% of the total. 2025 is the largest year on record at $15,137, more than ten times the $165 reported in 2019.

$37,324in general payments, 2019–2025

Across 167 payments — averaging $223.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$13K
  • Sirtex Medical Inc$12K
  • Guerbet LLC$6K
  • Boston Scientific$5K
  • Argon Medical Devices, Inc.$302
  • ABK Biomedical USA, Inc.$295
  • plus $1K from 9 others
$50,019in research payments, 2019–2025

Across 3 payments — averaging $16,673 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bard Peripheral Vascular, Inc.$49K
  • ABK Biomedical USA, Inc.$980

What the payments were for

  • Consulting fees$1,0983%
  • Speaking & faculty fees$10,40028%
  • Travel & lodging$19,01951%
  • Food & beverage$6,80818%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,324 in reported general payments places this provider in the 85th percentile of 38 vascular & interventional radiology providers in Utah.

See all vascular & interventional radiology providers in Utah

Medicare billing

Part B allowed, 2024
$89,643
Medicare patients
220
Services billed
832

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →